Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003191 |
---|---|
Receipt number | R000003652 |
Scientific Title | Cancer Vaccine Therapy using Epitope Peptide Restricted to HLA-A*24 (CDCA1,KIF20A) in Patients with Small Cell Lung Cancer Refractory to Standard Therapy (Phase I study). |
Date of disclosure of the study information | 2010/02/16 |
Last modified on | 2019/03/31 22:40:48 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/02/16 10:45:59 | ||
2 | Update | 2010/02/16 16:27:26 | Anticipated trial start date |
|
3 | Update | 2010/02/20 19:06:39 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
4 | Update | 2012/05/04 11:37:37 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2012/05/04 11:38:39 | Key inclusion criteria |
|
6 | Update | 2012/05/04 11:43:53 | Type of intervention Key inclusion criteria |
|
7 | Update | 2012/05/04 11:44:32 | Last name of lead principal investigator Name of person sending information |
|
8 | Update | 2012/12/06 14:59:39 | Last follow-up date |
|
9 | Update | 2019/03/31 22:40:48 | Recruitment status Date of IRB Last follow-up date |